<DOC>
	<DOCNO>NCT02318303</DOCNO>
	<brief_summary>Study evaluate two different strength dose regimen GSP 301 effective treatment seasonal allergic rhinitis .</brief_summary>
	<brief_title>To Study GSP 301 Patients With Seasonal Allergic Rhinitis</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Seasonal</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<mesh_term>Olopatadine Hydrochloride</mesh_term>
	<criteria>Key 1 . Aged ≥12 year older inclusive either sex . 2 . Documented clinical history SAR ( least 2 year precede Screening Visit [ Visit 1 ] ) exacerbation ( clinical evidence active symptom ) study season mountain cedar pollen 3 . A 12hour reflective TNSS ≥ 8 possible 12 congestion score ≥ 2 AM assessment Screening Visit ( Visit 1 ) . Key 1 . Pregnant lactating woman . 2 . Plans travel outside know pollen area investigative site &gt; 24 hour last 7 day run period . 3 . History nasal polyp clinically significant respiratory tract malformation , recent nasal biopsy , nasal trauma ( nasal pierce ) surgery , atopic dermatitis rhinitis medicamentosa . 4 . History anaphylaxis and/or severe local reaction ( ) skin test . 5 . History positive test HIV , Hepatitis B Hepatitis C infection . 6 . Documented evidence acute significant chronic sinusitis chronic purulent postnasal drip . 7 . Subjects active pulmonary disorder infection . 8 . Subjects posterior subcapsular cataract glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>